Table 1.
Drummond question | Community Pharmacy Medicines Management Project Evaluation Team (2007)12 | Dierick-van Daele et al, 201013 | Lee et al, 200414 | Neilson et al, 201515 | Richardson et al, 201316 | Turner et al, 200817 |
---|---|---|---|---|---|---|
Was a well-defined question posed in an answerable form? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Was a comprehensive description of the competing alternatives given? | ✓ | ✓ | ✓ | – | – | ✓ |
Was the effectiveness of the programmes or services established? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Were all the important and relevant costs and consequences for each alternative identified? | – | ✓ | ✓ | ✗ | ✓ | ✓ |
Were costs and consequences measured accurately in appropriate physical units? | – | ✓ | ✓ | ✓ | ✓ | ✓ |
Were costs and consequences valued credibly? | ✓ | ✓ | ✓ | ✓ | ✓ | |
Were costs and consequences adjusted for differential timing? | n/a | – | n/a | n/a | ✓ | ✓ |
Was an incremental analysis of costs and consequences of alternatives performed? | n/a | n/a | n/a | ✓ | ✓ | ✓ |
Was allowance made for uncertainty in the establishments of costs and consequences? | ✗ | ✓ | ✓ | ✓ | ✗ | |
Did the presentation and discussion of study results include all issues of concern to users? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Quality assessment score out of a possible 10 (including questions answered n/a)a | 7 | 9 | 9 | 8 | 9 | 9 |
Quality rating based on the number of Drummond questions answered: 0–5 = poor quality, 6–8 = moderate quality, >9 = good quality.11 ✓ = yes. ✗ = no. – = can’t tell. n/a = not applicable.